Mycobacterium tuberculosis
INTRODUCTION
Mtb (Mycobacterium tuberculosis), the causative agent of TB (tuberculosis), is once again established as a leading cause of human mortality worldwide [1] . Its re-emergence has been linked to its opportunistic infection of HIV-infected individuals, and to the increasing ineffectiveness of the most widely used antitubercular drugs (including antibiotics such as rifampicin, isoniazid and ethionamide) [2] . Antibiotic resistance, in turn, is associated with patients failing to complete courses of drugs, and as a consequence of mutations in target proteins that lead to diminished drug binding or their failure to activate pro-drugs (e.g. the common S315T mutation that leads to diminished efficiency of the Mtb catalase-peroxidase enzyme KatG in its activation of isoniazid to a toxic radical form) [3] . The World Health Organization has recognized the global threat to human health posed by multidrug-resistant strains of Mtb, and has highlighted the desperate requirement for novel therapies to combat antibiotic-resistant strains [4] .
The genome sequence of Mtb (strain H37Rv) determined by Cole et al. [5] revealed several unusual features and provided important information in the search for new antitubercular therapies. In particular, a large cohort of enzymes involved in the complex lipid metabolism of Mtb was revealed, and an unexpectedly large number (20) of CYP (cytochrome P450)-encoding genes were identified in the genome [6] . The P450s are mono-oxygenase enzymes involved in a diverse range of catalytic processes in organisms from all of the domains of life. The presence of so many P450s in Mtb (the Mtb CYP gene 'density' is ∼ 240-fold greater than in the human genome) indicates important roles in physiology and infectivity [6] . In particular, the identification of the first bacterial sterol demethylase P450 in Mtb, CYP51B1, highlighted the possibility that azole drugs might be effective as antituberculars [7, 8] . Azoles such as fluconazole, clotrimazole and econazole are widely used antifungal therapies that act by inhibiting the sterol demethylase CYP51 and so prevent synthesis of ergosterol, an important determinant of fungal membrane fluidity [9] . Recent studies of the effects of azole drugs on various mycobacteria and other actinobacteria showed that a number of these antibiotics were inhibitory to growth, and it was demonstrated that econazole was effective in clearing Mtb infection from the spleens of infected mice [6, 10, 11] .
The Mtb P450 enzymes require redox partner systems for electron delivery to the P450s to enable substrate oxidation. Typical bacterial P450 redox systems involve NAD(P)Hdependent, FAD-binding FDR (ferredoxin/flavodoxin reductase) enzymes, and ferredoxin proteins that mediate single electron transport to the P450s [12] . In Mtb, there are a number of ferredoxins identifiable in the genome sequence, and the 3Fe-4S ferredoxin Fdx (product of gene Rv0763c) is encoded adjacent to the CYP51B1 enzyme (Rv0764c) in the Mtb H37Rv genome [8, 13] . An obvious candidate FDR-type protein is FprA (flavoprotein reductase A), which has significant amino acid sequence and protein structural identity with mammalian mitochondrial AdR (adrenodoxin reductase) enzymes that participate in P450 redox systems involved in steroidogenesis [14] [15] [16] [17] . In previous studies, the expression and purification of FprA was reported, and the kinetic and thermodynamic features of the WT (wild-type) enzyme were established [14, 15] . FprA (along with the Mtb Fdx ferredoxin) was shown to support an electron transfer system that delivered electrons from NADPH to the Mtb P450 CYP51B1 and to the structurally resolved CYP121 [8, 13, 18] . FprA was shown to be reduced to the (neutral) blue SQ (semiquinone) form by NADPH, but fully to the HQ (hydroquinone) form by NADH, despite the identical redox potentials of these coenzymes [14, 19] . This finding revealed important differences in the nature of the interactions between FprA and NADPH/NADH, and pointed towards interactions between NADP(H) and reduced WT FprA that resulted in stabilization of the SQ form, and which did not occur with NAD(H) [15] .
To explore further this phenomenon and to rationalise coenzyme selectivity and its molecular basis in FprA, we investigated the effects of mutating residues predicted to be important in interactions with the 2 -phosphate group of NADP(H); the sole difference between this coenzyme and NAD(H). Examination of the atomic structure of Mtb FprA revealed that two arginine residues (Arg 199 and Arg 200 ) were likely to make favourable interactions with the 2 -phosphate group of NADP(H), and suggested that these residues could be critical in pyridine nucleotide coenzyme selectivity and in controlling the distinctive reductive processes observed with NADPH and NADH in the WT enzyme ( Figure 1 ) [14, 15] . In the present paper we report the detailed characterization of the R199A, R200A and R199A/R200A FprA mutants, revealing important roles for these basic residues in the regulation of coenzyme selectivity, flavin thermodynamics and catalytic efficiency of this important Mtb enzyme.
EXPERIMENTAL

Construction of FprA mutants
Mutagenesis of the fprA gene to create R199A, R200A and R199A/R200A mutants was done with the Stratagene QuikChange kit, using plasmid pKM3b (encoding WT FprA [15] ) as the template and Pfu Turbo ® DNA polymerase. Oligonucleotide primers used and the mutagenesis procedures employed are described in full in the Supplementary Data section, at http://www.BiochemJ.org/bj/417/bj4170103add.htm. All clones isolated were completely sequenced to ensure the presence of desired mutations and the absence of adventitious mutations.
Purification of WT FprA and FprA mutants
WT FprA and mutant proteins were produced in the T7 RNA polymerase lysogen strain HMS174 (DE3) (Novagen). HMS174 (DE3)/pFprA R199A, R200A and R199A/R200A transformants (typically 10-30 litres) were grown at 37
• C with vigorous agitation (220 rev./min) until mid-logarithmic growth phase 200 make stabilizing electrostatic interactions with the 2 -phosphate group of the NADP + . α-Helices are in cyan and β-sheet regions in magenta. Structural images were prepared using Pymol (DeLano Scientific) and the co-ordinates of the NADP + -bound form of FprA (PDB code 1LQT) [14] .
(D 600 ∼ 0.7) in either YT (yeast extract/tryptone) or Terrific Broth media [20] . Culture temperature was then decreased to 25
• C, and expression of WT and mutant fprA genes was induced by addition of IPTG (1 mM) once D 600 = 1.0. Culture growth was continued for 16-20 h. Cells (typically 30-50 g wet weight) were harvested and disrupted, and WT FprA protein was purified to homogeneity using methods established previously for WT and Trp359 mutants of FprA [15, 19] . Purification methods for the FprA mutants are described in more detail in the Supplementary Data section. Subsequent enzyme characterization was performed in 10 mM sodium phosphate, pH 7.5 (buffer A), unless otherwise stated. Purity of FprA proteins was assessed by spectral analysis (ratio of flavin-specific absorption [A 452 ] to protein-specific absorption [A 274 ]) and by SDS/PAGE of protein samples at different stages of purification. FprA concentration was determined using the oxidized enzyme coefficient: ε 452 = 10.6 mM −1 · cm −1 [15] .
Steady-state and stopped-flow kinetic analysis of mutant FprA enzymes
WT and mutant FprA-catalysed reduction of potassium ferricyanide was analysed by steady-state kinetic measurements using both NADH and NADPH as electron donors. NAD(P)(H) coenzymes were from Melford (Ipswich, U.K.). Kinetic parameters (K m , k cat ) for ferricyanide reduction were determined in buffer A and also in 50 mM Tris/HCl (pH 7.5) at 30
• C. Enzyme concentration was typically 50-100 nM. Ferricyanide concentration was maintained at 1.5 mM in reactions where NAD(P)H concentrations were varied (typically up to 1 mM coenzyme) to establish K m values for the coenzymes. In reactions where the concentration of the electron acceptor (ferricyanide) was varied, NAD(P)H concentrations were maintained at nearsaturating concentrations established from the preceding assays and confirmed in the present paper (200 μM for NADPH) [15] . Ferricyanide reduction was determined at 420 nm ( ε 420 = 1020 M −1 · cm −1 ). All measurements were in triplicate at each substrate concentration and all data points varied by < 5 % from the mean. The observed rate against substrate concentration values were fitted to the Michaelis-Menten function to establish the k cat and K m parameters, except in the case of data for NADHdependent reduction of ferricyanide in the R199A/R200A double mutant, where substrate inhibition was observed. In this case, values were fitted instead to a substrate inhibition equation (Equation 1) as follows; where k obs is the observed rate at substrate concentration S, K i is the dissociation constant for the substrate acting as inhibitor, and K m and k cat are the Michaelis-Menten parameters.
Stopped-flow studies of the reductive half-reaction of FprA mutants R199A, R200A and the double mutant R199/R200A were performed using an Applied Photophysics SX.18 MVR stoppedflow spectrophotometer contained within a glove box (Belle Technology, Portesham, U.K.) to maintain anaerobic conditions (< 5 p.p.m. oxygen). Flavin reduction by NADH/NADPH (up to 2.5 mM) was monitored by bleaching of the flavin in single wavelength mode at 452 nm (at the FprA flavin absorption peak) with enzyme concentration typically at 5-10 μM. Flavin reduction rates for mutant proteins were measured at 30
• C. All measurements were carried out in buffer A. All buffers were deoxygenated by evacuation and extensive bubbling with oxygenfree nitrogen. Prior to stopped-flow studies, protein samples were fully oxidized by treatment with potassium ferricyanide; and excess ferricyanide was removed by rapid gel filtration in the glove box (Pharmacia PD-10 column). Absorption transients from stopped-flow experiments were fitted to appropriate exponential functions using Spectrakinetics software (Applied Photophysics). Observed flavin reduction rates for FprA mutants reduced by NAD(P)H (k obs ) showed a hyperbolic dependence on coenzyme concentration. Rate against coenzyme concentration values were fitted to Equation 2 [21] to determine the apparent enzymecoenzyme dissociation constant, K d , and limiting rate of electron transfer to the FAD (k lim ). Values reported are averages of at least three separate determinations at each coenzyme concentration.
Stopped-flow, multiple-wavelength scanning absorption studies were also done using a PDA (photodiode array) detector and X-SCAN software (Applied Photophysics). Reactions were typically performed using an enzyme concentration of 40 μM in buffer A (20 μM in the final mixture) and over timescales up to 5 s after the initial mixing event, with the first spectrum generally recorded at 1.3 ms after mixing. NADH and NADPH (at concentrations up to 200 μM in the final mixture) were mixed with oxidized enzymes. Recorded spectra were then analysed globally using the Applied Photophysics ProKin software package, to investigate the formation of any distinct intermediate spectral forms and to define their rates of formation.
The oxidative half reaction was also investigated by the ability of sodium dithionite-reduced FprA mutants to pass electrons to NAD + and NADP + . R199A, R200A and the double mutant were made anaerobic and reduced by addition of a small excess of sodium dithionite in a glove box. The enzymes were separated from reductant by gel filtration using a BioRad Econo-Pac 10DG desalting column in the anaerobic box, pre-equilibrated with degassed buffer. The reduced enzyme was diluted to 20-40 μM in 50 mM sodium phosphate (pH 7.5) containing 5 % glycerol, and then mixed with NAD + or NADP + (up to a final concentration of 400 μM, i.e. 10-fold excess over the enzyme in the mixture) in the stopped-flow apparatus. Measurements of the rate of electron transfer from FprA to the coenzyme were made both in single wavelength mode (452 nm) and using a PDA as above. Data analysis was as described above for the reductive half-reaction.
Aerobic flavin reoxidation in FprA and its mutants (20 μM) was monitored at 30
• C in 100 mM potassium phosphate, pH 7.5, following addition of a stoichiometric amount of NAD(P)H. Reoxidation was measured through analysis of the rate of recovery of flavin absorption at 452 nm, and by fitting a single exponential function to the absorption versus time data using Origin 7.5 software (OriginLab, Northampton, MA, U.S.A.).
Spectroscopic analysis
All UV-visible absorption spectra and steady-state assays for FprA enzymes were recorded using a Cary UV-50 Bio UV-visible scanning spectrophotometer (Varian, Oxford, U.K.). Samples were suspended in buffer A for spectral analysis. Samples (typically ∼ 40-50 μM) were analysed using a 1 cm pathlength quartz cuvette. Circular dichroism (CD) measurements were performed at 20
• C using a JASCO J700 spectrapolarimeter with samples prepared in buffer A. Far-UV CD spectra were recorded from 190-260 nm in a quartz cell of 0.05 cm path length and with a scan rate of 10 nm/min. All spectra were recorded in triplicate and averaged. Protein concentrations used were 10.5 μM for far-UV CD measurements.
Analysis of flavin redox potentials
Potentiometric redox titrations to determine the midpoint reduction potentials of the FAD cofactor in the R199A, R200A and R199A/R200A FprA mutants were performed in a Belle Technology glove box under a nitrogen atmosphere, as described previously for WT and Trp359 mutants of FprA and for related enzymes [15, 19, 22] . All solutions were degassed under vacuum with nitrogen. Oxygen levels were always maintained at less than 2 p.p.m. 100 mM potassium phosphate, pH 7.0, containing 10 % (v/v) glycerol (titration buffer) was used in all potentiometric titrations. FprA proteins (typically 40-80 μM in ∼ 5 ml titration buffer) were titrated electrochemically according to the method of Dutton [23] . Details of mediators and the electrode system used are in the Supplementary Data section. Data manipulation and analysis were performed using Origin 7.5 software. For analysis of flavin midpoint potentials, absorbance data at 452 nm were plotted against applied potential and the data were fitted using a 2-electron Nernst equation to define the midpoint reduction potential for the 2-electron transition (i.e. the FAD oxidized/HQ redox couples) as described previously [23] [24] [25] .
RESULTS
Generation, expression and purification of FprA mutants
An examination of the crystal structure of Mtb FprA revealed the likely involvement of two arginine residues (Arg 199 and Arg 200 ) in interactions with the 2 -phosphate group of NADP(H) [14] . An analysis of the amino acid sequences of related FprA enzymes in other mycobacteria, AdR enzymes from various eukaryotes and other homologous enzymes revealed that these arginine residues were implicitly conserved, and thus likely to play important roles in coenzyme recognition/selectivity in all these enzymes (see Supplementary Figure S1 , at http://www.BiochemJ.org/ bj/417/bj4170103add.htm). To investigate roles of these residues, the three Mtb FprA mutants: R199A, R200A and the R199A/ R200A double mutant were generated by site-directed mutagenesis, verified by restriction digestion and DNA sequencing, and the encoded proteins isolated as described in the Experimental and Supplementary Data sections. Levels of fprA expression in the R199A and R200A mutant transformants was diminished compared with WT fprA, but a more extensive culture period (∼ 20 h rather than 12 h for WT fprA) resulted in production of comparable amounts of proteins (∼ 2 mg/litre culture). However, expression levels were further reduced for the R199A/R200A double mutant and only ∼ 0.5 mg of protein/litre of culture were recovered. Thus, larger scale protein production cultures were typically grown for the double mutant FprA transformant than for WT and point mutant transformants. The R199A and R200A and double mutant FprA proteins were purified using the same procedures as for WT FprA (chromatographic separations on phenyl Sepharose and QSepharose resins) until the stage of affinity chromatography (on 2 , 5 -ADP agarose) that was used successfully only for purification of WT FprA [15, 19] . The mutant proteins did not bind well to this resin, consistent with effects on the NADP(H) affinity caused by R199A and R200A mutations. Instead, a new chromatographic step using affinity for hydroxyapatite (see Experimental and Supplementary Data sections) was used to purify further the mutant proteins. WT and mutant FprA proteins were subjected to a final purification step by gel filtration on Sephacryl S-200 resin. The purified mutant proteins exhibited a final protein/flavin (FAD) absorbance ratio (A 274 /A 452 ) of < 7, consistent with that for WT FprA and indicative of pure holoprotein in each case.
Electronic absorption properties for oxidized WT and mutant FprA proteins
The electronic absorption properties of the R199A, R200A and R199A/R200A proteins were determined for the oxidized enzymes, and for the enzymes reduced with either NADPH, NADH or sodium dithionite. In their oxidized forms, the UVvisible absorption spectra were not significantly perturbed from those for the WT FprA. All had the typical flavin absorption bands at 452 nm and at 379 + − 1 nm, and exhibited a pronounced shoulder on the longer wavelength absorption band at 476 + − 1 nm (Figure 2 ). CD studies of the mutants in the far UV region (190-260 nm) revealed no significant changes compared with WT FprA and thus indicated that the secondary structural properties of FprA were not disrupted by the mutations (not shown). Thus, these mutations, which are located outside the immediate environment of the isoalloxazine ring, do not appear to grossly affect the electronic structure or environment of this redox-active portion of the oxidized FAD cofactor, or to affect protein folding. However, there were clear differences in the optical absorption spectra between WT and all of the mutant FprA proteins in their NADPHreduced forms. As observed previously, reduction with sodium dithionite (E m = − 420 mV) and with NADH (E m = − 320 mV, 100 μM) resulted in the conversion of WT FprA from its quinone (oxidized) state to its 2-electron reduced HQ form. However, reduction with NADPH (E m = − 320 mV, 100 μM) resulted in Table 1 Steady-state kinetic parameters for WT FprA and the R199A, R200A and R199A/R200A mutants Steady-state parameters were determined as described in the Experimental section. Reaction rate data were determined using an extinction coefficient of ε 420 = 1020 M −1 · cm −1 for ferricyanide reduction, and rate against NAD(P)H concentration data were fitted using a hyperbolic function to derive the reported k cat and K m parameters. Values in parentheses in the final column indicate the fold change in the catalytic efficiency (with NADH relative to NADPH) for the relevant mutant compared with WT FprA, based on the ratio of the specificity constants with NADH and NADPH as electron donors. For the double mutant only, data were fitted to a substrate inhibition equation (eqn 1) to produce the k cat and K m values detailed. The corresponding K i value determined for NADH with the double mutant (and using the same function) was 250 + − 52 μM. Figure 2 ). The stabilization of the SQ form of WT FprA was previously assigned to the tight binding of NADPH to both the oxidized and HQ forms of FprA, followed by electronic comproportionation between pairs of such molecules to form two molecules of NADPH-bound SQ FprA [15] . Thus, the destabilization of the FAD SQ in the FprA mutants (and particularly in those carrying the R199A mutation) was probably due to diminished affinity for NADP(H) and/or to altered thermodynamic properties of the flavin. To probe further the effects of mutations on FprA and coenzyme selectivity/electron transfer, we examined the kinetic properties of WT and FprA using steady-state and stopped-flow approaches.
Steady-state kinetic analysis of WT and mutant FprA enzymes
In previous studies, it was shown that ferricyanide was a good substrate for reduction by WT FprA, using both NADPH and NADH coenzymes as the electron donors. The WT FprA K m value for NADPH was substantially lower than that for NADH [15, 26] . To determine the influence of the R199A, R200A and R199A/R200A mutations on the catalytic efficiency with the different coenzymes in steady-state turnover, analysis of the reduction of ferricyanide was done both to determine (i) the k cat and K m parameters for the coenzymes (with ferricyanide at a near-saturating concentration of 1.5 mM) and (ii) the same parameters for ferricyanide (with NADPH at 200 μM; a concentration established as near-saturating from the initial set of assays at a fixed ferricyanide concentration). Data collected using buffer A are presented in Table 1 . A parallel data set was also collected in 50 mM Tris/HCl buffer (pH 7.5), and showed little relevant variations from the data presented in [15] . For each of the R199A, R200A and double mutants, FAD reduction transients fitted well to a single exponential function with both NADH and NADPH as reducing coenzymes. With NADH (in all cases) the dependence of FAD reduction rate on coenzyme
Table 2 Kinetic parameters for NAD(P)H-dependent reduction of FAD in WT and mutant FprA enzymes
Data reporting on FAD reduction in WT and R199A, R200A and R199A/R200A FprA mutants were collected using stopped-flow absorption spectroscopy as described in the Experimental section. The values for the limiting rate of electron transfer from coenzyme to FAD (k lim ) and the apparent dissociation constant for the coenzyme (K d ) are derived from hyperbolic fits of observed FAD reduction rates against the relevant coenzyme concentrations. In the case of WT FprA, there was no apparent dependence of the observed NADPH-dependent FAD reduction rate in the pseudo first-order regime, and thus a value for K d was not determinable (ND).
* For WT FprA, the value reported for k lim is the rate observed at near-saturating concentrations of NADPH. values with NADPH were similar to those for WT FprA, but apparent affinity for NADPH was diminished in the single mutants, and the effect was compounded in the double mutant. Exemplary data sets describing the relationship between FAD reduction rate and coenzyme concentration are shown for the NADPHdependent reduction of the R200A variant and the R199A/R200A double mutant in Figure 3 and Supplementary Figure S2 (at http://www.BiochemJ.org/bj/417/bj4170103add.htm) respectively. The insets show examples of fitted flavin reduction transients from the respective data sets. Photodiode array stopped-flow spectroscopy studies of the NAD(P)H-dependent reduction of the FprA mutants were performed to follow spectral development during flavin reduction. These studies demonstrated reductive transitions between oxidized (quinone) and 2-electron reduced (HQ) forms of the FAD cofactor, and with no evidence for any formation of blue SQ species seen at equilibrium in the reaction between WT FprA and NADPH [15] . These data were thus consistent with equilibrium reduction spectra shown in Figure 2 and further confirmed the destabilization of the blue SQ species induced by both the R199A and R200A mutations in FprA. Figure 4 (panels A and B) shows exemplary PDA data sets for the NADPH-dependent reduction of the R199A and R200A mutants, respectively.
Analysis of the oxidative reactions of reduced FprA mutants
Previous stopped-flow studies of the reactions of WT FprA with NAD(P)H demonstrated that there was negligible reoxidation of the dithionite-reduced (HQ) enzyme with NAD + as the oxidant (under anaerobic conditions), but that there was rapid partial reoxidation with NADP + as the oxidant, leading to a final species with spectral properties similar to that obtained for the reductive reaction between oxidized FprA and NADPH at a similar concentration (i.e. with blue SQ FAD formed) [15] . In view of the perturbations to the NAD(P)H binding site induced by the R199A and R200A mutations (alone and in combination), we examined the oxidative reaction of the dithionite-reduced mutants with NAD(P)
+ on a stopped-flow time scale by both PDA and single wavelength analysis to monitor FAD electron transfer to the coenzyme under anaerobic conditions. It was found that incubation of dithionite-reduced enzymes in buffer A resulted in some enzyme precipitation over time, and for this reason oxidative reactions were done in 50 mM sodium phosphate (pH 7.5) containing 5 % glycerol to aid protein stability. As with WT FprA, and even at the highest concentrations of NAD + used (200 μM, a 10-fold excess over the enzyme concentration), there was negligible oxidation of the R199A, R200A and R199A/R200A mutants (< 3 %) over periods of up to 200 s following the mixing event. With NADP + as the oxidizing coenzyme, substantial reoxidation was observed for the R200A mutant, but the R199A and R199A/R200A mutants showed a far lower level of reoxidation ( Figures 4C and 4D ). For the R200A mutant, the enzyme reoxidizes to ∼ 40 % completion (with 200 μM NADP + as oxidant) within 0.5 s after the stoppedflow mixing event, and there is clear development of a long wavelength CT (charge transfer) species immediately after mixing of the R200A HQ FprA with NADP + , which subsequently decays as the process of electron transfer to NADP + (forming NADPH) progresses ( Figure 4D ). This CT species occurs due to the reaction between the reduced FAD and the oxidized coenzyme, and is indicative of productive interaction between the coenzyme nicotinamide and the FAD isoalloxazine ring in readiness for the electron transfer event. In contrast, the R199A and R199A/R200A mutants reoxidize to only ∼ 5 % completion over 200 s, and there is no evidence of formation of a CT complex, suggesting that the R199A mutation results in disorientation of the oxidized coenzyme nicotinamide ring in the FprA active site, such that electron transfer from the FAD to NAD(P) + in the reduced (HQ) R199A and R199A/R200A mutants becomes inefficient. In single wavelength (452 nm) anaerobic stoppedflow absorption studies, the reaction of the reduced R200A FprA enzyme with NADP + (up to 500 μM) was analysed, and a hyperbolic dependence of FAD oxidation rate (determined by fitting reaction transients with a single exponential function) on coenzyme concentration was obtained, producing parameters of k lim = 58.1 + − 0.2 s −1 and K d = 11.6 + − 0.2 μM. However, this rate of (partial) reoxidation of R200A FADH 2 to NADP + remains substantially lower than was reported previously for WT FprA (> 300 s −1 ) [15] . In view of the disruption of the NAD(P)H binding site induced by the R199A and R200A mutations, and in light of the altered reactivity with NAD(P) + above, we also examined the reoxidation of the reduced WT and all mutant FprA enzymes (20 μM) under aerobic conditions with molecular oxygen as the electron acceptor. Enzymes were reduced with stoichiometric NADH or NADPH, as described in the Experimental section. The reoxidation rate data are presented in Table 3 . It is clear that with NADH as the reductant, the oxidation rate for WT FprA (1.26 + − 0.06 min −1 ) is not substantially different from those of the other mutants, although the R199A variant reoxidizes slightly slower than WT FprA (0.88 + − 0.03 min −1 ). However, with NADPH as the reductant there is a substantial difference in oxidation rate for WT FprA compared with the situation with NADH as reductant. The NADPH-reduced WT FprA oxidizes much more slowly (0.043 + − 0.004 min −1 ), probably as a consequence of its higher affinity for NADP(H), which in turn enables stabilization of the blue SQ species. In contrast, each of the NADPH-reduced mutants reoxidize ∼ 18-26 fold faster than the WT FprA (Table 3) . These data emphasize the importance of the binding of NADP(H) coenzyme in the stabilization of the reduced forms of FprA, Table 3 Aerobic oxidation rates for WT and mutant forms of FprA
The rate of reoxidation of WT and mutant FprA enzymes with oxygen as the electron acceptor was determined using enzymes (20 μM) stoichiometrically reduced with coenzyme, and as described in the Experimental section [15] . An exponential function was fitted to the data to generate the rate constants detailed. and reinforce the detrimental effects of the arginine mutations on both the affinity for NADP(H) and the resultant enhanced auto-oxidation of the mutants.
Thermodynamic analysis of the FprA mutants
The preceding studies of reduction potentials of WT FprA demonstrated the absence of stabilization of blue SQ during equilibrium titrations with dithionite (reductant) and ferricyanide (oxidant). Similar phenomena were observed in redox titrations of the R199A, R200A and R199A/R200A mutants, highlighting the importance of NADP(H) coenzyme binding in stabilizing the SQ form. The midpoint 2-electron reduction potential for WT FprA is − 230 + − 12 mV, and this was not significantly altered (− 235 + − 5 mV) when the protein was bound to a non-redox active analogue of NADPH, H 4 NADP (tetrahydro-NADP) [8] . FAD reduction potentials were determined for the ligand-free and H 4 NADP-bound forms of the R199A, R200A and R199A/R200A mutants. Results are presented in Table 4 . In all cases, there was negligible stabilization of SQ in the titrations. However, in all cases the FAD potential was more positive than that for WT FprA (by ∼ 38-65 mV), indicating a change in FAD isoalloxazine environment in all cases. For the R199A mutant, the potential was not considerably altered in the H 4 NADP complex. However, for both the R200A and R199A/R200A mutants, the FAD potential was much more negative in the H 4 NADP complex, and in the case of the R200A mutant the potential was decreased by 41 mV and to a value identical within error to that for the WT FprA H 4 NADP complex ( Figure 5 ). The data demonstrate that the environment of the FprA FAD is perturbed in the arginine mutants, leading to positive changes in the FAD midpoint potential compared with WT, and that the binding of the coenzyme analogue H 4 NADP causes negative shifts in potential, and particularly for those variants carrying the R200A mutation.
DISCUSSION
Arginine residues corresponding to Arg 199 and Arg 200 are widely conserved in FprA-and AdR-like enzymes from several organisms (see Supplementary Figure S1 ). Analysis of the Mtb FprA atomic structure suggested that both these arginines are important to the binding of the 2 -phosphate group of NADP(H) coenzyme, while Arg 199 also interacts with the adenosine moiety through π-π stacking interactions [14] . In view of the unusual ability of FprA to stabilize a blue SQ FAD only with NADPH as reductant, we created the R199A, R200A and R199A/R200A mutants and performed detailed catalytic, kinetic, spectroscopic and thermodynamic studies to investigate the roles of these residues. In previous studies, the stabilization of the neutral blue The midpoint reduction potential (E m ) for the FAD cofactor in WT, R199A, R200A and R199A/R200A FprA enzymes was determined by spectroelectrochemical titration, as described in the Experimental section [8, 30] . Potentials are reported relative to the standard hydrogen electrode (SHE). An overlay of the data fits (using a 2-electron Nernst function, as described previously [8, 25, 31] ) for the ligand-free R200A mutant () and for the H 4 NADP-bound form (᭺). The fits were computed using A 452 data (at the oxidized FAD maximum), and then data were converted to 'FAD oxidized (%)' using the parameters generated and in order to show both data sets on exactly the same scale. H 4 NADP-binding results in a 41 mV decrease in reduction potential from − 192 mV to − 233 mV.
SQ form of the WT FprA FAD was assigned to the binding of NADPH to both the reduced (HQ) and oxidized forms of FprA, followed by electronic comproportionation to produce the SQ species as the predominant form [15, 26] . While only minor effects were observed on secondary structure or oxidized spectra of the mutant proteins, equilibrium reduction with NADPH (or NADH) results in near complete HQ formation, suggesting that NADP(H) binding is destabilized in comparison with WT FprA. This was consistent with the finding that the arginine mutants no longer bound an NADP(H) coenzyme affinity resin, and with higher mutant K m values for NADPH (Table 1) . Stopped-flow FprA FAD reduction studies also demonstrated that NADPH affinity was diminished in mutants, with K d values increasing in the order R199A < R200A < R199A/R200A ( Table 2 ). The K m values for NADH were improved in all mutants, suggesting an important role for the Arg 199 and Arg 200 in discriminating against this coenzyme, and k cat /K m ratios also indicated a substantial specificity switch towards NADH in the mutants (Table 1 ). For its role in an Mtb P450 redox system, FprA provides electrons one at a time to ferredoxin(s), which themselves are obligate one-electron transfer proteins [27] . Thus, it is feasible that the NADPH-dependent stabilization of the FprA SQ is related to its preferred electron transfer mechanism in a class I P450 redox system. However, it is also clear that the oxidation of FAD in NADPH-reduced WT FprA is substantially slower (18-fold or more) than in the arginine mutants, which also points to this being a mechanism for avoiding auto-oxidation and wastage of reducing equivalents in vivo (Table 3) .
Potentiometry showed that all mutations resulted in more positive FAD reduction potentials, indicating perturbation of the isoalloxazine environment, despite the arginines not being involved directly in bonding interactions with this redox active portion of the FAD cofactor. Binding of the redox inactive NADPH analogue H 4 NADP to FprA variants containing the R200A mutation resulted in a negative shift in FAD midpoint potential (∼ 30-40 mV) consistent with this mutation affecting the binding mode of H 4 NADP such that the FAD environment is perturbed in the complex. No substantial shifts in FAD potential were noted for H 4 NADP-bound WT or R199A FprA (Table 4 ) [15] . Interestingly, the oxidative reaction of HQ R200A FprA with NADP + results in transient formation of a CT species between reduced enzyme and oxidized coenzyme (FADH 2 :NADP + ), followed by a rapid electron transfer reaction until an equilibrium mixture of FADH 2 /NADP + and FAD/NADPH species is produced ( Figure 4D ). The observed rate of this oxidative reaction (at 200 μM NADP + ) is slower for R200A FprA (58.1 s −1 ) than for WT FprA (> 300 s −1 ), but remains an efficient process. By contrast, negligible NADP + -dependent oxidation occurs for the R199A or double mutant FprA enzymes, indicating that Arg199 plays a critical role in facilitating the orientation of the NADP + coenzyme and its nicotinamide to enable electron transfer in the oxidative direction. Negligible electron transfer from the FADH 2 species occurs to NAD + on a stopped-flow timescale for WT or any of the arginine mutants.
FprA probably plays a pivotal role in supporting the activity of several Mtb P450 enzymes. We have previously demonstrated FprA-dependent electron transport to the Mtb CYP51B1 and CYP121 P450s [8, 28] . A number of Mtb P450s have been shown to bind various azole drugs tightly, and selected azoles were also shown to be effective in treatment of TB in a mouse model [8, 10, 11] . However, drug targeting against FprA may prove a challenge given its structural similarity to host AdR and other reductases, and thus coenzyme analogue inhibitors are very unlikely to prove specific to FprA. Antitubercular pro-drugs such as isoniazid and ethionamide have nicotinamide-like moieties and are activated (by the catalase-peroxidase KatG and the Baeyer-Villiger monooxygenase EtaA) to reactive forms that have at least one common nicotinamide coenzyme-dependent target; the NADH-dependent enoyl-acyl carrier protein reductase InhA [29, 30] . While it is conceivable that other NAD(P)H-dependent Mtb enzymes are targeted by these drugs, there is no proof to date that FprA is one such target.
In conclusion, characterization of FprA R199A, R200A and R199A/R200A mutants highlights the importance of these phylogenetically conserved residues in controlling the thermodynamic properties and reactivity of FprA. Arg 199 and Arg 200 are clearly critical residues controlling the affinity of binding of NADPH (and hence stabilization of the SQ form of FprA leading to its greater stability to auto-oxidation), in controlling coenzyme selectivity (NADPH against NADH) and in modulating FAD potential (probably through long-range interactions 
EXPERIMENTAL
Construction of FprA mutants
Mutagenesis of fprA to generate R199A, R200A and R199A/ R200A mutants was performed using the Stratagene QuikChange kit and plasmid pKM3b (encoding WT FprA), as described in the main paper. Primers used for mutagenesis were obtained from MWG Biotech. The following primers were used to create R199A, R200A and R199A/R200A mutants. The sequences of the forward (F) primers are given below. Reverse (R) primers are the exact complements of the forward primers. Nucleotides in bold are those altered from the WT sequence; nucleotides underlined show a restriction site for the indicated enzyme:
DNA restriction and ligase enzymes were from NEB or Stratagene. PCR reactions were performed in a 50 μl volume containing ∼ 25 ng of template DNA, 125 ng of each F and R mutant primer, 0.2 mM dNTPs and 2.5 units of Pfu polymerase in the manufacturer's buffer. PCR was performed using a Techne Genius Thermocycler with an initial denaturing step at 95
• C for 30 s, followed by 18 cycles of 95
• C (30 s), 63
• C (1 min) and 68
• C (8 min). PCR products were digested with DpnI to cleave methylated parental DNA template, 1 μl of the mixtures was transformed into XL-1 Blue competent cells, and cells were [6, 7] . grown on LB agar plates at 37
• C overnight [1] . Transformants were used to prepare plasmid DNA (i.e. pET11a containing fprA mutant genes) using the Sigma GenElute purification kit. Plasmids were completely sequenced to verify mutations at MWG Biotech, using primers described previously for WT fprA [2] and MWG's T7 and T7 term oligonucleotide primers. Desired mutations, and absence of secondary mutations, were confirmed for the R199A, R200A and R199A/R200A variants.
Purification of WT FprA and FprA mutants
Purification of WT FprA was performed as described in the main paper and in previous references [2, 3] . For the three FprA mutant proteins (R199A, R200A and R199A/R200A), diminished affinity for the coenzyme affinity resin (2 ,5 -ADP-Sepharose column) used to purify WT FprA led to the adoption of a different purification scheme in these cases. Following the initial purification steps used for all FprA proteins [ammonium sulfate fractionation followed by hydrophobic affinity (phenyl-Sepharose) and ion exchange chromatography on Q-Sepharose resin], the R199A, R200A and R199A/R200A mutants were further purified by pooling and dialysing appropriate Q-Sepharose fractions into 25 mM potassium phosphate (pH 6.5) in the presence of protease inhibitors (benzamidine hydrochloride and PMSF, both at 1 mM), and then loading onto hydroxyapatite resin (5 × 20 cm) equilibrated in the same buffer. Bound protein was eluted in a 500 ml linear gradient of 25-500 mM potassium phosphate (pH 6.5). Appropriate mutant FprA-containing yellow fractions were retained, concentrated by ultrafiltration (Centriprep 30 Data were collected using stopped-flow absorption spectroscopy, as described in the Experimental section of the main paper. The Figure shows a plot of observed FAD reduction rate against NADPH concentration for the FprA R199A/R200A mutant. Eqn (2) was fitted to the data to provide parameters for the limiting rate constant for FAD reduction (22.2 + − 0.5 s −1 ) and for the apparent K d for the coenzyme (88.6 + − 7.7 μM). A similar data set for the R200A mutant is presented as Figure 3 in the main paper.
concentrator, Millipore) and dialysed into 50 mM potassium phosphate (pH 7.5) plus 5 % (v/v) sterile glycerol and protease inhibitors, and then the sample was applied on to a gel filtration column (Sephacryl S-200, 2 × 50 cm). The FprA proteins were eluted from the column using the same buffer. Fractions of the highest purity (A 274 /A 452 < 7) were collected, pooled and concentrated by ultrafiltration as before, and then exchanged extensively into 10 mM sodium phosphate (pH 7.5) containing glycerol (50 % v/v) by dialysis, prior to storage of the pure enzymes at − 80
• C.
Analysis of flavin redox potentials
Midpoint reduction potentials were determined using the method described in the main paper. Mediators (2 μM phenazine methosulfate, 5 μM 2-hydroxy-1,4-naphthoquinone, 0.5 μM methyl viologen and 1 μM benzyl viologen) were added to facilitate electrical communication between enzyme and electrode, prior to titration [4, 5] . Electrochemical potential of the solution was measured using a Hanna pH 211 meter coupled to a Pt/Calomel electrode (ThermoRussell Ltd) at 25 + − 2 • C. The electrode was calibrated using the Fe 3+ /Fe 2+ EDTA couple as a standard (+ 108 mV). A factor of + 244 mV was used to correct relative to the standard hydrogen electrode (SHE).
